Lactosylceramide (LacCer), which is essential for many cellular processes, is highly expressed on the plasma membranes of human neutrophils and mediates innate immune functions. Less is known, however, about the properties and biological functions of LacCer in mouse neutrophils. This study therefore analyzed the properties of mouse neutrophil LacCer. LacCer was observed on the surface of these cells, with flow cytometry indicating that mouse neutrophil LacCer could be detected by the anti-LacCer mAb T5A7, but not by the anti-LacCer antibodies Huly-m13 and MEM-74. The molecular species of LacCer were nearly identical in mouse and human neutrophils, including C24:0 and C24:1 fatty acid chain-containing species, although the LacCer content in plasma membranes was ∼20-fold lower in mouse than in human neutrophils. Surface plasmon resonance analysis revealed that T5A7 bound to a lipid monolayer composed of LacCer, DOPC, cholesterol and sphingomyelin (molar ratio 0.1 : 10 : 10 : 1), whereas Huly-m13 did not. T5A7 induced neutrophil migration, which was abolished by inhibitors of Src-family kinases, PI-3 kinases, and trimeric G (o/i) proteins. T5A7 also inhibited phagocytosis of non-opsonized zymosans by neutrophils. Taken together, these findings suggest that in mouse neutrophils, (i) LacCer is expressed as LacCer-enriched microdomains in cell surface plasma membranes, (ii) these microdomains are recognized by T5A7 but not by other known antiLacCer antibodies and (iii) LacCer is involved in cell migration and phagocytosis.
Introduction
Glycosphingolipids (GSLs) are composed of hydrophobic ceramide and hydrophilic sugar moieties and are expressed primarily on the outer leaflet of plasma membranes (Degroote et al. 2004 ). More than 400 GSL species have been identified based on their sugar chain structures (Hakomori 2003) . The expression of GSLs is altered in specific manners in a variety of cell types during cell proliferation and differentiation (Hakomori 2003; Sonnino et al. 2006) , indicating that the expression patterns of GSLs may reflect their cellular functions. Genetically modified mice have been developed to clarify the molecular mechanisms underlying the physiological functions of GSLs (Mizukami et al. 2002; Nishie et al. 2010; Nagafuku et al. 2012) .
A neutral GSL lactosylceramide (LacCer; Galβ4Glcβ1Cer), also called CD17 (CDw17) (Stain et al. 1987) , has been shown to bind to many species of pathogenic bacteria and yeast, including Escherichia coli, Bordetella pertussis, Bacillus dysenteriae, Propionibacterium freudenreichii and Candida albicans (Karlsson 1986; Saukkonen et al. 1992; Angstrom et al. 1998; Zimmerman et al. 1998; Abul-Milh et al. 1999; Hahn et al. 2003; Sato et al. 2006) , suggesting that LacCer is involved in pathogen-host interactions in mammals. In rats, Pneumocystis carinii-derived β-glucan induces the production of MIP-2 from alveolar epithelial cells via LacCer expressed on these cells (Hahn et al. 2003) . In mature human neutrophils, >70% of GSLs are LacCer (Symington et al. 1985) . LacCer undergoes clustering to form LacCer-enriched microdomains (lipid rafts) with signal transducer molecules (e.g. Lyn) on plasma membranes (Iwabuchi and Nagaoka 2002; Nakayama et al. 2008) . Polysaccharide β-1,6-long glycoside side-chain-branched β-1,3-D-glucans isolated from Candida albicans ("Candida soluble β-glucans"; CSBGs) induce chemotaxis of neutrophils via LacCer-enriched microdomains (Sato et al. 2006) . Ligand binding-induced activation of CD11b/CD18 integrin, which initiates rearrangement of the actin cytoskeleton and consequent translocation of CD11b/CD18 into Lyncoupled LacCer-enriched microdomains, allows neutrophils to phagocytose non-opsonized microorganisms via CD11b/CD18 ). These observations indicate that LacCer-enriched microdomains function as pattern recognition receptors (PRRs) on the neutrophil surface and play an important role in the bactericidal functions of human neutrophils.
Less is known, however, regarding the function of LacCer in neutrophils of nonhuman mammalian species. The major swine pathogen Streptococcus suis type 2 has been reported to affect the stability of LacCer-enriched microdomains and to inhibit phagocytosis through LacCer in J774 mouse macrophages (Houde et al. 2012) . Mice are the experimental tool of choice for the majority of immunologists, and the study of immune responses in mice has provided considerable insight into human immune system function (Mestas and Hughes 2004) . We have therefore characterized LacCer in mouse neutrophils. Although we found that the amount of LacCer expressed on the surface of mouse neutrophils is small, these cells displayed LacCer-mediated chemotaxis and phagocytosis.
Results

LacCer expression on mouse neutrophils
As the initial step in characterization of LacCer in mouse neutrophils, we evaluated LacCer expression on the surface of mouse blood cells by flow cytometry. Mouse peripheral blood cells were isolated using citrate solution to remove platelets, which express LacCer (Chatterjee 1998) , from monocytes (Rinder et al. 1991) . CD11b is a cell surface marker for human monocytes/macrophages as well as for neutrophils (Hickstein et al. 1987; Daley et al. 2008) . The GPI-anchored protein Ly6G is highly expressed on mouse neutrophils but not on monocytes (Hestdal et al. 1991) . We thus defined mouse neutrophils as CD11b + / Ly6G + cells ( Figure 1B ) (Hestdal et al. 1991 ).
All anti-LacCer monoclonal antibodies (mAbs) available to date are mouse IgM antibodies. We found that normal mouse IgM itself bound strongly to mouse neutrophils (data not shown). To analyze the specific binding of anti-LacCer to these cells, the latter were pretreated with normal mouse IgM and then incubated with one of three anti-LacCer mAbs, T5A7, Huly-m 13 and MEM-47, all of which have been shown to bind to LacCer antigens (Zola et al. 2007) . Under these experimental conditions, CD11b + /Ly6G + cells were positively stained with anti-LacCer mAb T5A7 ( Figure 
Molecular species of LacCer derived from plasma membrane and neutrophil granules
The ability of the anti-LacCer mAb T5A7 to bind to mouse neutrophils suggested that these cells express LacCer on their plasma membranes. Using high-performance thin-layer chromatography (HPTLC), we found that LacCer was a minor lipid component of plasma membranes and granules of peritoneal neutrophils ( Figure 2 ). The amount of LacCer in the plasma membrane fraction was estimated by densitometric analysis as 0.18 ± 0.06 µg/10 8 cells (mean ± SD of 3 experiments), much lower than the 3.7 ± 0.17 µg/10 8 cells observed in the plasma membrane fraction of human neutrophils . LacCer was also recovered from the detergent-resistant membranes (DRMs) of whole mouse neutrophils ( Figure 2 ) and from the plasma membranes and granules of human neutrophils (Iwabuchi and Nagaoka 2002) . To further confirm the presence and characterize the distribution of LacCer molecular species in mouse neutrophils, we analyzed the LacCer-containing fractions of HPTLC by reverse-phase liquid chromatography/electrospray ion trap mass spectrometry (LC-ESI-MS n ).
Several LacCer species differing in ceramide structure were detected in the lipids of the plasma membrane and granules ( Figure 3 ). There were no fundamental differences in the LacCer species of mouse and human neutrophils, and the distribution patterns of LacCer species were almost identical in the plasma membranes and granules of mouse neutrophils. The major LacCer species isolated from plasma membrane of mouse neutrophils were similar to those of human neutrophils and included C16:0-, C22:0-, C24:0-, and C24:1-fatty acid chains containing LacCer.
Binding avidity of anti-LacCer mAbs to LacCer
To clarify the difference in binding affinity of Huly-m13 and T5A7 to LacCer on mouse neutrophils (Figure 1 ), we analyzed the surface plasmon resonance (SPR) of their binding to a lipid monolayer. Based on the lipid composition of the DRM fraction of human neutrophils ), we created a lipid monolayer, consisting of a mixture of porcine blood cell-derived LacCer, DOPC, cholesterol, and sphingomyelin (molar ratio 1 : 10 : 10 : 1), on an HPA sensor chip. The binding affinity of T5A7 [average maximum resonance units (RU) 3506.5] was higher than that of Huly-m13 (average maximum RU 3009.4) (Figure 4) . We also prepared a lipid monolayer with a 10-fold lower proportion of LacCer (DOPC/LacCer/cholesterol/ sphingomyelin in molar ratio 0.1 : 10 : 10 : 1) to reflect findings in the DRM fraction of mouse neutrophils. T5A7 bound to this lowLacCer lipid monolayer, but Huly-m13 did not. Under our experimental conditions, neither of these anti-LacCer antibodies bound to DOPC/cholesterol/sphingomyelin monolayer, nor to 0.2 µmol GlcCer-or GalCer-contained lipid monolayers (data not shown).
These results suggested that the binding affinities of T5A7 and Huly-m13 to LacCer depend on the amount of LacCer in the domains. LacCer species with very long fatty acids are specifically necessary for LacCer-mediated neutrophil functions Nakayama et al. 2008) . Porcine blood cell-derived LacCer is composed of several kinds of fatty acid chains (Kaga et al. 2005) . To assess the effect of LacCer fatty acid chain length on the binding affinities of anti-LacCer antibodies, we coated HPA sensor chips with lipid monolayers containing LacCer with C16:0, C22:0, C24:0 and C24:1 fatty acid chains and analyzed the binding of T5A7 and Huly-m13 by SPR. The binding affinities of T5A7 and Huly-m13 to 0.2 µmol of these LacCers were almost identical ( Figure 4C and D) , whereas the binding affinities of T5A7 to 0.02 µmol of these LacCers were ∼3-fold lower ( Figure 4E ). Huly-m13 bound slightly to C16:0, but not to C22:0-, C24:0-and C24:1 LacCer-containing lipid monolayers ( Figure 4F ).
These findings indicate that the binding affinities of anti-LacCer antibodies to LacCer were independent of fatty acid chain length.
Effect of grade of phospholipid unsaturation on the binding of anti-LacCer antibodies to LacCer
The unsaturation grade of PC has been reported to affect the size of GSL domains (Ohta et al. 2004) . To further characterize the binding specificities of T5A7 and Huly-m13, we compared their binding to plastic wells coated with DOPC/LacCer, POPC/LacCer and DPPC/LacCer liposomes, and to LacCer in ethanol solution without or with DOPC, POPC or DPPC. T5A7 and Huly-m13 bound to POPC/LacCer and DOPC/LacCer liposome-coated plastic wells, but only slightly to DPPC/LacCer liposome-coated plastic wells ( Figure 5A and C). T5A7 and Huly-m13 bound equally to wells coated with LacCer mixed with DOPC, POPC and DPPC ( Figure 5B and D). Interestingly, the binding affinity of Huly-m13 to LacCer-coated plastic wells was the same as to wells coated with DOPC/LacCer, POPC/ LacCer and DPPC/LacCer mixtures, while the binding affinity of T5A7 to LacCer-coated plastic wells was much weaker than to plastic wells coated with DOPC/LacCer, POPC/LacCer or DPPC/LacCer ( Figure 5B ). To confirm the involvement of the carbohydrate moiety in the binding of anti-LacCer antibodies to LacCer, we examined the inhibitory effect of lactose on the binding of these antibodies to DOPC/ LacCer liposome-coated and DOPC/LacCer mixture-coated plastic wells. Lactose dose-dependently and significantly inhibited the binding of T5A7 and Huly-m13 to DOPC/LacCer liposome-coated wells ( Figure 5E ). Interestingly, lactose inhibited the binding of Huly-m13 to DOPC/LacCer mixture-coated wells, whereas a lactose concentration higher than 50 mM was needed to inhibit the binding of T5A7 to DOPC/LacCer mixture-coated wells ( Figure 5F ).
Although T5A7 had higher binding affinity than Huly-m13 (Figure 4) , the binding avidity of T5A7 to LacCer-coated plastic wells was weaker than that of Huly-m13 ( Figure 5 ). To clarify whether the binding mechanisms of these two antibodies to LacCer differ, we performed a double-labeling experiment using the same LacCercoated plastic plates and stimulated emission depletion (STED) microscopy. Huly-m13 and T5A7 bound to distinct LacCer domains/ clusters on the same liposomes and the same LacCer/DOPC-coated plastic wells (Figure 6 ), suggesting that the binding sites for these two mAbs are not always the same.
Effect of Ca
2+ on the binding of anti-LacCer antibodies to LacCer
Using model membranes, the divalent cation Ca2 + has been shown to interact with gangliosides (Rahmann et al. 1992) , suggesting that binding of GSLs and membrane microdomains to other molecules is Ca 2+ dependent (Koshy et al. 1999; Babiychuk et al. 2000) . Neutrophil migration, phagocytosis and superoxide generation are Ca 2+ -dependent functions (Lew et al. 1985; Silliman et al. 2003) and were affected by the anti-LacCer antibodies T5A7 and Huly-m13 (Iwabuchi and Nagaoka 2002; Sato et al. 2006; Yoshizaki et al. 2008 , with this binding completely abolished by ethylene glycol-bis(2-aminoethylether)-N,N,N′,N ′-tetraacetic acid (EGTA; Figure 7A and B). The mean fluorescence signal of T5A7 was higher in the presence than in the absence of Ca 2+ Fig. 2 . HPTLC analysis of plasma membrane and granule fractions of mouse neutrophils. Lipid components were extracted from plasma membrane and granule fractions and DRM of mouse bone marrow-derived neutrophils and from DRM of human peripheral blood neutrophils, as described in Materials and Methods. The lipid extracts were analyzed by HPTLC using primulin spray. LacCer, porcine blood-derived LacCer. Arrows indicate migration positions of LacCer. experiments) of each LacCer molecular species relative to total LacCer bands. "a", mixture of LacCer (d18:2/C16:0) and LacCer (d18:1/C16:1). "others", sum of other LacCer species, which accounted for <1% of total LacCer intensity.
(293.8 ± 24.5 vs 128.6 ± 28.8). In the presence of Ca
2+
, T5A7 bound to clusters of LacCer on plasma membranes of peripheral blood neutrophils ( Figure 7C ). To understand the mechanism underlying Ca 2+ enhancement of the binding of anti-LacCer antibodies to mouse neutrophils, the effects of Ca 2+ on the binding of anti-LacCer antibodies to LacCer were analyzed by SPR and ELISA. Ca 2+ did not affect the binding affinity of either T5A7 or Huly-m13 to LacCer (data not shown). To test the effects of Ca 2+ on the intermolecular interactions of LacCer, DSC was measured from 20 to 85°C for LacCer and LacCer/chol in the presence or absence of 12.5 mM Ca
. After the first heating-cooling cycle, stable thermograms were obtained for up to eight scans. Although the main phase transition temperature (76.6°C) for LacCer while heating was not altered by the addition of Ca 2+ , the transition enthalpy was increased from 6.68 to 8.71 kcal/mol ( Figure 7D ). In addition, the exothermic transition peak (negative deflection at ∼62°C) while heating was slightly lower in the presence than in the absence of Ca 2+ ( Figure 7D ), with the main phase transition temperature slightly increased, from 73.2 to 73.7°C, and the enthalpy increased from 5.71 to 6.38 kcal/ mol. The exothermic transition observed for pure LacCer at ∼62°C was significantly broadened for the LacCer/chol mixture but the addition of Ca 2+ restored the exothermic peak at ∼56.3°C. The main phase transition peak while cooling became sharper in the presence than in the absence of Ca
. These results suggest that Ca 2+ slightly enhances intermolecular interactions of LacCers in the membrane. The structural properties of LacCer/chol in the presence of Ca were further investigated by small-angle X-ray scattering. Up to four lamellar diffractions from dispersions of LacCer/chol mixtures were observed before (25°C) and after (75°C) the main phase transition temperature ( Figure 7E ). Lamellar distances were almost unaltered by the addition of Ca 2+ . The first diffraction peak indicated that the lamellar distances of LacCer/chol were 7.36 nm at 25°C and 6.83 nm at 75°C. Although these lamellar distances were almost The values shown are mean ± SD of three independent experiments. *P < 0.05; ***P < 0.001. (C-F) C16:0-, C22:0-, C24:0-, or C24:1-LacCer at 0.2 µmol (C and D) or 0.02 µmol (E and F) was mixed with DOPC (2 µmol), cholesterol (2 µmol) and sphingomyelin (0.2 µmol) in chloroform/methanol solution and dried. The lipid mixture films were resolved in HBS-N buffer, mixed vigorously with a vortex mixer and sonicated. The resulting liposome solutions were immobilized on an HPA sensor chip using HBS-N buffer. The chip surface was washed briefly with 50 mM NaOH and blocked with 100 µg/mL BSA. For analysis, 20 µg/mL T5A7 (C and E) or Huly-m13 (D and F) was injected. This figure is available in black and white in print and in colour at Glycobiology online.
unaltered by Ca 2+ , the overall scattering profiles and diffraction peaks were broader for LacCer/chol in the absence than in the presence of Ca 2+ , suggesting that the lamellarity of LacCer/chol was lower in the absence of Ca
. Therefore, physiological concentrations of Ca 2+ are unlikely to directly affect the headgroup conformation of LacCer perpendicular to the plane of the membrane.
Effect of anti-LacCer mAbs on neutrophil functions
Since T5A7 induced the chemotaxis of human neutrophils , we examined the effects of T5A7 on the migration of mouse neutrophils using a Boyden chamber assay. T5A7, when present in the lower chamber only, significantly enhanced neutrophil migration with a bell-shaped dose-response curve ( Figure 8A ). In contrast, when T5A7 was present in both the upper and lower chambers, neutrophil migration was not significantly enhanced. These findings suggest that the effect of T5A7 on mouse neutrophils is chemotactic (directional cell movement of cells toward concentration gradients of CSBG) rather than chemokinetic (random cell movement in the absence of CSBG gradients), similarly to findings with human neutrophils (Sato et al. 2006 ). The anti-LacCer mAb Huly-m13 did not have a significant effect on neutrophil migration ( Figure 8B ), in agreement with flow cytometry results. These findings indicate that T5A7 and Huly-m13 differ in their ability to recognize LacCer, suggesting that mouse LacCer has a specific form or conformation to which only T5A7 can bind effectively. β-Glucans are natural ligands of LacCer expressed on plasma membranes of human neutrophils (Zimmerman et al. 1998; Sato et al. 2006) . Among various types of β-glucans, CSBGs induce chemotaxis via LacCer in human neutrophils, whereas β-1,6-monoglucosyl-branched β-glucans, such as Sparassis crispa-derived β-glucans (SCGs), do not (Sato et al. 2006) . To test whether the recognition system for β-glucans is similar in mouse and human neutrophils, we evaluated the migration . After washing and blocking with BSA, the plates were sequentially incubated with several concentrations of T5A7 (A and B) or Huly-m13 (C and D). The wells were subsequently washed and incubated with HRP-conjugated goat anti-mouse IgM. The bound antibodies were quantitatively measured using a TMB Peroxidase EIA substrate kit. Data are presented as mean ± SD of three independent experiments. •, DOPC /LacCer; △, POPC/LacCer; ○, DPPC /LacCer; □, LacCer; ▪, DOPC. (E and F) T5A7 or Huly-m13 (2.5 µg/mL) was incubated with several concentrations of lactose in wells coated with DOPC/LacCer liposomes (E) and a DOPC/LacCer mixture (F) for 2 h at room temperature. The wells were washed and incubated with HRP-conjugated goat anti-mouse IgM. The bound antibodies were quantitatively measured by TMB Peroxidase EIA substrate kit.
•, T5A7; ○, Huly-m13. Data are presented as mean ± SD of three independent experiments. *P < 0.05, ***P < 0.001 compared with the binding of antibodies at the same lactose concentration.
of mouse peritoneal neutrophils toward β-glucans and anti-LacCer mAbs. Neither CSBGs nor SCGs (each 10 µg/mL) induced migration of mouse neutrophils ( Figure 8B ).
Human neutrophils migrate toward T5A7, a process involving the Src-family kinase Lyn and PI3 kinases . In mouse neutrophils, the Src-family kinase inhibitor PP1 significantly blocked T5A7-induced migration, while the negative control PP3 did not ( Figure 8C ). In human neutrophils, Lyn is associated with LacCer and is essential for LacCer-mediated chemotaxis and phagocytosis (Sato et al. 2006; Nakayama et al. 2008) . Plasma membrane-derived LacCer and Lyn were localized in DRM fractions of mouse neutrophils ( Figure 5D ). Since Huly-m13, but not T5A7, immunoprecipitates LacCer-enriched microdomains from human neutrophils (Iwabuchi and Nagaoka 2002) , we examined the possible association of Lyn with LacCer-enriched membrane microdomains in mouse neutrophils. Unfortunately, we were unable to isolate these microdomains using Huly-m13.
In human neutrophils, LacCer-mediated chemotaxis is dependent on protein phosphatase 1, phosphatidylinositol-3 kinase (PI-3K) and heterotrimeric G-proteins (Sato et al. 2006 ). T5A7-induced neutrophil migration was significantly inhibited by the PI-3K inhibitor LY294002 and by wortmannin, but not by LY303511, a negative control for LY294002 (Figure 8C ). A G alpha (i/o) inhibitor pertussis toxin also significantly inhibited T5A7-induced neutrophil migration.
Human neutrophils phagocytose non-opsonized zymosan in a LacCer-dependent manner . Zymosan is a particle derived from Saccharomyces cerevisiae and is coated with β-glucans (Di Carlo and Fiore 1958; Zimmerman et al. 1998) . Mouse neutrophils also phagocytose non-opsonized zymosans.
We assayed the effects of anti-LacCer mAbs on such phagocytosis to evaluate the possible involvement of LacCer. T5A7, but not Huly-m13, significantly inhibited this phagocytic activity ( Figure 4D ), suggesting that mouse neutrophils have a LacCer-dependent phagocytosis mechanism. Dectin-1 has been identified as the primary β-glucan receptor on mouse macrophages and neutrophils (Brown et al. 2002; Taylor et al. 2007 ). Although dectin-1 was not localized in DRM fractions ( Figure 8D ), anti-dectin-1 mAb 2A11 significantly suppressed the phagocytic activity of mouse neutrophils (Figure 9 ). This activity was also inhibited in a synergistic fashion by a combination of 2A11 and T5A7, suggesting that both dectin-1 and T5A7 are involved in neutrophil recognition and zymosan phagocytosis.
We previously demonstrated LacCer-dependent superoxide generation in human neutrophils (Iwabuchi and Nagaoka 2002) . Under the experimental conditions of the present study, however, T5A7-induced superoxide anion production by mouse neutrophils was negligible (data not shown).
Discussion
To our knowledge, this is the first demonstration of LacCer expression on the plasma membrane of mouse neutrophils by flow cytometry. Although the amount of LacCer was much lower in mouse than in human neutrophils, mouse neutrophils contained LacCer-enriched microdomains and displayed LacCer-mediated migration and phagocytosis. The lack of commercially available anti-LacCer mAb T5A7 may have prevented thorough investigations of LacCer-mediated functions in mouse neutrophils. Electron microscopy studies using labeled anti-GSL antibodies have revealed GSL clusters on the surface of GSL/PC liposomes, even in the absence of sphingomyelin and cholesterol (Hakomori 2003) . LacCer forms clusters, consisting of LacCer-enriched microdomains, on plasma membranes . The anti-LacCer mAbs T5A7 and Huly-m13 recognized LacCer on human neutrophils, but only T5A7 recognized LacCer on mouse neutrophils. Interestingly, Huly-m13 but not T5A7 can be used for immunoprecipitation ), suggesting a difference in binding and/or cluster formation of Huly-m13 and T5A7 to LacCer-enriched microdomains. Indeed, Huly-m13 and T5A7 bound to distinct LacCer domains/clusters on the same liposomes and the same LacCer/DOPC-coated plastic wells. The relative amount of LacCer in the plasma membrane was ∼20-fold lower in mouse than in human neutrophils. Moreover, SPR analysis showed that reduction of the LacCer content in the DOPC/cholesterol/ LacCer/sphingomyelin lipid layer markedly decreased Huly-m13 binding to LacCer, suggesting that the content of LacCer in LacCer-enriched microdomains affects the binding avidity of Huly-m13 to LacCer. The binding avidity of Huly-m13 to LacCer-coated plastic wells was similar to its avidity to DOPC/LacCer, POPC/LacCer and DPPC/LacCer mixturecoated plastic wells, indicating that the binding of Huly-m13 to LacCer coated onto plastic wells was not affected by DOPC, POPC or DPPC. Moreover, lactose inhibited the binding of Huly-m13 to LacCer/DOPC liposome-coated and DOPC/LacCer mixture-coated plastic wells, suggesting that Huly-m13 may bind only to LacCer clusters in LacCer-enriched microdomains. In contrast, the binding avidity of T5A7 to LacCer-coated plastic wells was much weaker than to DOPC/LacCer-, POPC/LacCerand DPPC/LacCer mixture-coated wells, suggesting that the binding of T5A7 to LacCer is affected by PC. The ability of lactose to inhibit the binding of T5A7 to DOPC/LacCer liposome-coated plastic wells was similar to its ability to inhibit the binding of Huly-m13. In contrast, lactose inhibition of T5A7 binding to DOPC/LacCer mixture-coated plastic wells was significantly lower than its inhibition of Huly-m13 binding, suggesting that T5A7 recognizes the PC-enhanced three-dimensional structure of LacCer clusters. Lysenin was shown to specifically bind to "clustered" sphingomyelin on sphingomyelin/PC/cholesterol liposomes, whereas equinatoxin II preferentially binds to dispersed sphingomyelin, although both molecules are specific binding toxins for sphingomyelin (Makino et al. 2014 . Under our experimental conditions, at 0°C, it is unlikely LacCer was released from storage sites in granules (Iwabuchi et al. 2012 (Hauser et al. 1975; Boettcher et al. 2011) . Thus, Ca 2+ may interact with phospholipids, forming large LacCer-enriched domains, although additional experiments are required to confirm this hypothesis. The migration of human neutrophils toward β-glucans (CSBGs) is mediated by LacCer (Sato et al. 2006) . Although mouse neutrophils did not migrate toward CSBGs, T5A7 induced neutrophil migration. While the identity of the natural ligand remains unclear, LacCer-enriched microdomains evidently play some role in chemotaxis of mouse neutrophils. Fig. 8 . Effect of anti-LacCer mAbs on neutrophil migration. (A) Chemotactic activity of T5A7 toward mouse peripheral blood neutrophils using the Boyden chamber method. T5A7 in DMEM/F12 medium supplemented with 0.1 mg/mL BSA was added to the upper or lower compartment as described in Materials and Methods. fMLP (50 nM) was used as a positive control for the neutrophil migration assay. T5A7 induced significant neutrophil migration with a bell-shaped dose-response curve. The results shown are the mean ± SD of 5-8 independent experiments. **P < 0.01; ***P < 0.001. (B) T5A7, Huly-m13, anti-CD15 IgM (MC-480), or normal mouse IgM (each 1 µg/mL) was mixed with 10 µg/mL SCGs or CSBGs, and 10 nM fMLP or DMSO in DMEM/F12 medium supplemented with 0.1 mg/mL BSA was placed in the lower compartments, as indicated. IgM-pretreated neutrophils in DMEM/F12 medium supplemented with 0.1 mg/mL BSA were placed in the upper compartment. Results shown are the mean ± SD of 5-8 independent experiments. *P < 0.05. (C) T5A7 (1 µg/mL) in DMEM/F12 medium supplemented with 0.1 mg/mL BSA was placed in the lower compartment. Normal IgM-pretreated neutrophils preincubated with 10 µM PP1, 10 µM PP3, 2 µM LY294002, 2 µM 303511, 100 nM wortmannin or 20 ng/mL pertussis toxin in DMEM/F12 medium supplemented with 0.1 mg/mL BSA at 4°C for 30 min was then placed in the upper compartment. The results shown are the mean ± SD of 5-8 independent experiments. *P < 0.05; ***P < 0.001. (D) Plasma membranes of mouse neutrophils (3 × 10 9 equivalent cells) were lysed in Triton X-100-containing lysis buffer, homogenized and subjected to sucrose-density gradient centrifugation.
A series of 1-mL fractions was taken starting from the top, and the lipid extract from each fraction was analyzed by HPTLC. To investigate Lyn and dectin-1, the fractions obtained from sucrose-density gradient centrifugation were subjected to SDS-PAGE/immunoblotting with anti-Lyn and anti-dectin-1 IgG.
T5A7 alone significantly suppressed phagocytosis of nonopsonized zymosan by mouse neutrophils, and T5A7 in combination with anti-dectin-1 mAb 2A11 suppressed such phagocytosis in a synergistic manner. Dectin-1 is essential for the recognition of β-glucans in mouse macrophages and neutrophils (Brown et al. 2002; Taylor et al. 2007 ). Lyn-coupled LacCer-enriched microdomains are essential for CD11b/CD18-mediated phagocytosis of non-opsonized zymosans by human neutrophils ). Dectin-1 was recently shown to activate Mac-1 on recruited neutrophils. Thus, LacCerenriched microdomains and dectin-1 are likely both involved in the phagocytic process in mouse neutrophils.
LacCer binds to a variety of microorganisms ) and forms Lyn-coupled microdomains and functions as a PRR on human neutrophils (Iwabuchi et al. 2012) . Mouse macrophages display LacCer-dependent phagocytosis (Houde et al. 2012) . LacCer is expressed on human monocytes/macrophages and dendritic cells (Kina et al. 2011 ). Although we were unable to biochemically isolate LacCer-enriched microdomains from mouse neutrophils, our pharmacological experiments indicated that mouse neutrophils contain LacCer-enriched microdomains and that LacCer mediates chemotaxis through Lyn-, PI3K-and heterotrimeric G-protein-dependent signal transduction. Thus, LacCer-enriched microdomains may function as PRRs in mouse phagocytes, although to date there is no direct evidence for LacCer expression on mouse monocytes. Studies are in progress to further elucidate the characteristics and functions of LacCer-enriched microdomains in mouse blood cells.
Materials and methods
Antibodies and reagents
Mouse anti-LacCer monoclonal IgM T5A7 was prepared as described (Symington et al. 1985) . Mouse anti-LacCer IgM mAb Huly-m13 was from Ancell Corp (Bayport, MN). Mouse anti-LacCer IgM MEM-74, mouse anti-CD15 IgM MC-480, PE-conjugated rat anti-mouse Ly6G
IgG, PerCP-Cy5.5-conjugated rat anti-mouse CD11b IgG M1/70 and FITC-conjugated mouse anti-CD5.1 IgM mAbs were from BD Bioscience (San Jose, CA). Rat anti-mouse dectin-1 mAb 2A11 was from Hycult Biotechnology (Uden, The Netherlands). Rabbit polyclonal anti-Lyn IgG was from Santa Cruz Biotechnology (Santa Cruz, CA). Normal mouse IgM was from Seikagaku Co. (Tokyo, Japan). Porcine LacCer, cholesterol, Galβ1-4Glc-ceramides, 1,2-di-oleoyl-sn-glycero-3-phosphocholine (DOPC) and egg sphingomyelin were from Matreya (Pleasant Gap, PA). C16:0-( palmitic acid), C22:0-(behenic acid) and C24:0-(lignoceric acid)-LacCer were kindly provided by Dr Sandro Sonnino (University of Milan). Cholesterol, wortmannin, dimethylsulfoxide (DMSO) and N-formylmethionineleucine-phenylalanine (fMLP) were from Sigma-Aldrich Japan (Tokyo, Japan). CSBGs and SCGs were kindly provided by Dr Hiroshi Tamura (Seikagaku Corp.) and Drs Yoshiyuki Adachi and Naohito Ohno (Tokyo University of Pharmacy and Life Science), as described (Sato et al. 2006 ). PP1 and PP3 were from Biomol Research Laboratories (Plymouth Meeting, PA). LY294002, LY303511 and pertussis toxin were from Calbiochem (La Jolla, CA). All other reagents were of analytical grade.
Solvent ratios are by volume unless indicated otherwise.
Cell preparation
Mouse neutrophils were isolated from 10-week-old male C57BL/6 mice (Sankyo Labo Service Co., Tokyo, Japan). Bone marrow cells were obtained by flushing femurs with sodium citrate buffer (0.4% sodium citrate, 0.85% NaCl, pH 7.4). To isolate peripheral blood neutrophils, citrate anti-coagulated peripheral blood was collected from the heart (Takaya et al. 2005) . Neutrophils were isolated from peritoneal exudates 4-5 h after i.p. injection of 3 mL of 4% thioglycollate (Difco Laboratories, Detroit, MI), as described (Seino et al. 1998) . Isolated cells were washed with 0.3 mM EDTA-containing Dulbecco's phosphate-buffered saline (EDTA-PBS). Neutrophils were further purified from the isolated cells by the Percoll selfgenerated gradient method (Boxio et al. 2004 ) and suspended in PBS or DMEM/F12 medium (10 7 cells/mL). In some experiments, neutrophils were purified using EasySep™ Mouse Neutrophil Enrichment Kits (Stemcell Technologies). The neutrophil populations were >95% pure, as determined by Wright-Giemsa staining and estimation of Gr-1 + cells by flow cytometry. Mononuclear cells were isolated from citrated anti-coagulated peripheral blood by Lympholyte-M cell separation medium (Nycomed Pharma Axis-Shield, Oslo, Norway). These isolated cells were always >99% viable, as determined by trypan blue dye exclusion (Wako, Osaka, Japan). Human neutrophils were isolated from heparinized peripheral blood of healthy volunteer subjects, with their informed consent, using Polymorphprep (Nycomed Pharma). The purity of these cells was >95% as estimated by Wright-Giemsa staining. The membrane and granule fractions of the cells were isolated by the nitrogen cavitation method, as described (Iwabuchi and Nagaoka 2002) .
Flow cytometric analysis
To evaluate the expression of LacCer on mouse leukocytes, 5 × 10 5 cells were pretreated with 1 µg/mL normal mouse IgM in PBS for 10 min on ice, and then incubated with 1 µg/mL PerCP-Cy™5.5-conjugated anti-mouse CD11b IgG, PE-conjugated anti-mouse Ly6G IgG, and 1 µg/mL Alexa647-conjugated anti-LacCer IgM or normal mouse IgM in PBS for 30 min on ice. The cells were washed with PBS, and fluorescent signals were detected by FACSCalibur (BD Biosciences). In some experiments, cells were incubated in Fig. 9 . Effect of anti-LacCer mAbs on neutrophil phagocytosis of non-opsonized zymosans. Neutrophils were preincubated on ice for 30 min without or with 10 µg/mL normal mouse IgM (IgM), MC-480, Huly-m13, T5A7 or anti-dectin-1 IgG 2A11, or mixtures of 10 µg/mL T5A7 and 2A11 (T5A7 + 2A11) or normal mouse IgM and IgG (IgM + G). A 10-fold excess of Alexa-647-labeled zymosan was added, and the cells were incubated for 45 min at 37°C in the presence of the mAbs. Neutrophils were fixed with 2% PFA and observed with an SP2 laser-scanning confocal microscope. Each bar shows the mean ± SD of six independent experiments. **P < 0.01; ***P < 0.001. DMEM/F12 with 2 mM CaCl 2 or 10 mM EGTA on ice for 10 min, and then incubated with 1 µg/mL biotinylated T5A7 or Huly-m13. Following incubation, the cells were washed and stained with Alexa647-conjugated streptavidin in the same solutions, and fluorescent signals were analyzed.
Confocal microscopic analysis
To observe the expression of LacCer on mouse neutrophils by confocal microscopy, cells were incubated with Alexa488-conjugated T5A7 in PBS with or without 0.07 mM CaCl 2 at 4°C for 30 min. The cells were washed with ice-cold PBS and fixed with periodatelysine paraformaldehyde (PLP) fixative solution (2% paraformaldehyde 0.1 M lysine in 50 mM sodium phosphate buffer, pH 7.4) for 30 min on ice. The cells were again washed with PBS and monitored using an SP2 laser-scanning confocal microscope at 100× (Leica Microsystems K.K., Tokyo, Japan).
Molecular species analysis of LacCer from mouse neutrophil membrane and granule fractions
To isolate plasma membranes and granules, neutrophils were disrupted by nitrogen cavitation (Iwabuchi and Nagaoka 2002) , and the plasma membrane and granule fractions were isolated by the differential centrifugation method with some modifications (Vaissiere et al. 1999) . Briefly, neutrophils (2 × 10 7 cells/mL) were suspended in relaxation buffer [100 mM KCl, 3 mM NaCl, 3.5 mM MgCl 2 , 1 mM ATP-2Na, 10 mM piperazine-1,4-bis(2-ethanesulfonic acid), pH 7.3] and disrupted by nitrogen gas cavitation for 20 min at 350 psi on ice. The cavitated fraction was placed in EGTA solution (final concentration 1.25 mM, pH 7.4). The cell homogenates were centrifuged at 500 × g for 10 min at 4°C, and the resulting supernatants were centrifuged at 8500 × g for 20 min at 4°C to isolate granules (termed "granule fraction"). The resulting supernatants were centrifuged at 200,000 × g for 60 min at 4°C to isolate plasma membranes (termed "plasma membrane fraction"). Lipid components of these fractions were extracted with chloroform : methanol (2 : 1) solution and analyzed by HPTLC with chloroform : methanol : 0.3% CaCl 2 60 : 25 : 4 (v/v/v) (Iwabuchi and Nagaoka 2002) , with the migrated lipids and GSLs visualized with primulin spray. The molecular species of each component extracted from the HPTLC plate was identified by LC-ESI-MS n analysis as described (Kaga et al. 2005 ).
SPR analysis
LacCer-containing liposomes were prepared as described (Sato et al. 2006) . In brief, 0.2 or 0.02 µmol LacCer in chloroform : methanol (2 : 1) solution was mixed with 2 µmol DOPC, 2 µmol cholesterol and 0.2 µmol sphingomyelin in the same solution and dried under a nitrogen stream. The dried residue was suspended in 200 µL HBS-N buffer (20 mM 4-(2-hydroxyethyl)-1-piperizineethanesulfonic acid (HEPES), pH 7.4, 150 mM NaCl), mixed vigorously with a Vortex mixer and sonicated for 15 min with a water bath sonicator (SND Co., Nagano, Japan). The liposome solutions were filtered with a 0.22-µm polyvinylidene difluoride (PVDF) syringe-driven filter unit (Millipore Co., Darmstadt, Germany). SPR was measured using a BIAcore 3000 analytical system (GE Healthcare, Uppsala, Sweden) with HPA sensor chips. Each chip was pretreated with 40 mM n-octyl-β-D-glucoside for 5 min at a flow rate of 5 µL/min. The 10-fold diluted liposome solutions were immobilized on the chips for 30 min at a flow rate of 2 µL/min, using HBS-N buffer without or with 1 mM CaCl 2 and 1 mM MgSO 4 as running buffer. The chip surfaces were washed with 50 mM NaOH for 1 min at 5 µL/min and blocked with 100 µg/mL bovine serum albumin (BSA). For analysis, 20 µg/mL T5A7 or Huly-m13 was injected at a flow rate of 5 µL/min. Signals generated in a negative control chip without LacCer were subtracted from the experimental values. Quantitative evaluation of the binding and dissociation reactions was performed using BIAevaluation software, version 3.1, which was provided with the apparatus (Papo and Shai 2003) .
Enzyme-linked immune solvent assay
The binding specificity of anti-LacCer antibodies to LacCer was assayed by enzyme-linked immune solvent assays (ELISA) using LacCer liposomes and lipid solutions in ethanol, as described previously with modifications (Sato et al. 2006; Ichikawa et al. 2009 ). The liposome solutions were prepared as described in the SPR analysis section of the "Materials and methods" and diluted 20-fold, with 50 µL of solution placed in each well of 96-well NUNC Immuno™ plates (NUNC™, Denmark), followed by overnight incubation at room temperature with gentle shaking. To coat plates with solutions of lipid mixtures, the dried materials composing these solutions were dissolved in 4 mL ethanol rather than HBS-N buffer and sonicated briefly, with 50 µL of solution placed in each well of 96-well NUNC Immuno™ plates, followed by drying overnight at room temperature with gentle shaking. The coated plates were blocked with 1% BSA in PBS for 5 h at room temperature, washed with PBS, and incubated with various concentrations of T5A7 or Huly-m13 in 1% normal goat serum (NGS) for 2 h at room temperature. In some experiments, 2.5 µg/mL T5A7 or Huly-m13 with 1% NGS was incubated with various concentrations of lactose or sucrose in DOPC/LacCer liposome-or DOPC/LacCer lipid mixture-coated plastic wells for 2 h at room temperature. The wells were extensively washed with PBS and incubated with HRP-conjugated goat anti-mouse IgM for 1 h at room temperature. After further washes, the amounts of solid phase-bound antibodies were measured using TMB Peroxidase EIA Substrate Kits (Bio-Rad Laboratories, Hercules, CA) using a Wallac 1420 multilabel counter (Perkin Elmer Japan, Tokyo, Japan).
STED microscopic observation
To assess the binding patterns of T5A7 and Huly-m13 to LacCerenriched domains on 96-well NUNC Immuno™ plates by STED microscopy, the LacCer/DOPC liposomes in PBS and LacCer and DOPC mixture in ethanol were coated onto the back surfaces of the plates, followed by overnight incubation at room temperature with gentle shaking. The chemical compositions of the back surface and of the wells of the plate were identical. The coated plates were blocked with 1% BSA in PBS for 5 h at room temperature, washed with PBS and sequentially stained with Alexa488-T5A7and ATTO425-Hulym13 for 30 min at room temperature. The plates were subsequently viewed under a TCS STED CW super-resolution microscope (Leica Microsystems K.K., Tokyo, Japan) and imaged using a 1.4 NA × 100 objective lens (Leica). Signals were detected using a GaAsP hybrid detection system (Leica), with deconvolution performed using Huygens STED deconvolution option software (Leica).
Small-angle X-ray scattering
A lipid film of LacCer/chol (1 : 0.5 mol/mol) was formed from a chloroform solution of lipids under a stream of nitrogen gas, dried in high vacuum overnight, hydrated and vortexed with 20 mM HEPES buffer ( pH 7.0) solution containing 100 mM NaCl and 10 mM EDTA, or 100 mM NaCl and 12.5 mM CaCl 2 . The final concentration of LacCer was 10 mM. Small-angle X-ray scattering Characterization of mouse neutrophil LacCer (SAXS) was performed at RIKEN Structural Biology Beamline I (BL45XU) at SPring-8, 8 GeV synchrotron radiation source, Hyogo, Japan, at an X-ray wavelength of 0.9 Å and a beam size at the sample position of ∼0.4 × 0.7 mm 2 . The sample temperature was controlled with a high precision thermoelectric device. SAXS results were recorded with a 10 s exposure using a beryllium-windowed X-ray image intensifier coupled to a cooled CCD camera (1000 × 1018 pixels). The recorded images were subjected to the required corrections (Ito et al. 2005) . Buffer profiles were also measured to subtract background. The two-dimensional powder diffraction patterns were circularly averaged and reduced to one-dimensional profiles using FIT2D version 12.012 (http://www.esrf.fr/computing/scientific/ FIT2D/), a 2D data reduction and analysis program. Reciprocal spacing (s), s = 1/d = (2/λ)sin θ (where d is the lattice spacing, 2θ is the scattering angle and λ is the wavelength of X-ray), was calibrated with silver behenate by the long-period spacing of 5.838 nm (Huang et al. 1993 ).
Differential scanning calorimetry
Lipid samples of LacCer and LacCer/chol were prepared for DSC. Briefly, a lipid film was formed from a chloroform solution of lipids under a stream of nitrogen gas, dried overnight under high vacuum, hydrated and vortexed with a buffer solution containing 20 mM HEPES, pH 7.0, and either 100 mM NaCl and 10 mM EDTA or 100 mM NaCl and 12.5 mM CaCl 2 . The final concentration of LacCer was 0.5 mM. DSC studies were performed with a MicroCal (Northampton, MA) VP-DSC microcalorimeter at a scan rate of 30°C /h. DSC scanning was performed at least 8 times, with representative data shown in Figure 5 . The obtained data were plotted and analyzed with Origin (OriginLab Corp., Northampton, MA).
Preparation of low-density DRM fractions
DRM fractions were isolated from 3 × 10 8 mouse neutrophils and from plasma membrane and granule fractions of mouse (1 × 10 9 equivalent cells) and human (1 × 10 8 equivalent cells) neutrophils, as described (Iwabuchi and Nagaoka 2002) . Following sucrose-density ultracentrifugation, a series of fractions was obtained, starting from the top of the ultracentrifuge tube. For immunoblotting analysis, 20-µL aliquots of fractions were electrophoresed on 7.5% SDS-PAGE gels and transferred to PVDF membranes, and the membranes were incubated with rabbit anti-Lyn IgG, followed by SuperSignal reagent (Takara Bio Inc., Shiga, Japan). To analyze the distribution of LacCer in the sucrose-density gradients, lipids of each fractions were isolated using C18 Bond Elut packed columns (1 mL, C18, Analytichem International, Harbor, CA) and subjected to HPTLC analysis ).
Lipid component analysis of DRM and subfractions
The membrane subfractions immunoseparated with antibodies were mixed with 1 mL of methanol, sonicated for 15 min, mixed with 2 mL chloroform and further sonicated for 5 min. To extract lipids from liquid samples, 10 volumes of methanol were added, and the mixtures were sonicated for 15 min in a water bath sonicator. Each was mixed with 20 volumes of chloroform, followed by sonication for 5 min, and centrifugation at 1500 × g at 4°C for 15 min. The supernatants were collected, dried under an N 2 stream, sonicated in methanol, mixed with water to yield a methanol : water ratio of 3 : 7 (v/v), and again sonicated. The solutions were extracted with chloroform/methanol (2 : 1, v/v) and preequilibrated with methanol/water (3 : 7). The columns were extensively washed with distilled water, and bound materials were eluted with 2 mL of chloroform/methanol (2 : 1) followed by 1 mL of chloroform. The eluates were dried under N 2 and dissolved in ∼20 µL of chloroform/methanol (2 : 1).
Migration assay
Cell migration was assayed using a modified Boyden chamber with cellulose nitrate filters ( pore size 3 µm; Sartorius, Göttingen, Germany), as described (Sato et al. 2006) . Briefly, fMLP (50 nM) or mAbs (1 µg/mL) in DMEM/F12 medium supplemented with 0.1 mg/mL BSA was placed into the lower compartment of a chamber, and a neutrophil suspension pretreated with normal mouse IgM (2.5 × 10 6 cells/mL; 300 µl suspension) in DMEM/F12 medium containing 0.1% BSA was placed into the upper compartment, followed by incubation for 30 min at 37°C in a CO 2 incubator. In some experiments, neutrophils were preincubated with 10 µM PP1, 10 µM PP3, 2 µM LY294002, 2 µM 303511, 100 nM wortmannin or 20 ng/mL pertussis toxin at 4°C for 30 min and then placed in the upper compartment. After incubation, the filters were fixed with neutral buffered formalin for 20 min and stained with Mayer's hematoxylin. The distance (µm) from the top of the filter to the furthest two cells in the same focal plane was measured microscopically with a 40× objective in 20 fields across the filter, and the results were expressed as the migration index (relative neutrophil migration: average distance of tested group/average distance of corresponding vehicle control). In each assay, fMLP was used as a positive reference chemoattractant.
Phagocytosis assay
Phagocytosis was assayed by the method described for human neutrophils (Hua et al. 2002) . Mouse neutrophils (8 × 10 6 cells/mL in DMEM/F12) were treated with 10 µg/mL normal mouse IgM for 10 min on ice, washed with DMEM/F12 medium, and preincubated on ice for 30 min with 10 µg/mL MC-480, Huly-m13, T5A7 or anti-dectin-1 IgG 2A11, or mixtures of 10 µg/mL T5A7 and 2A11. Alexa-647-labeled zymosan was added at a 10-fold excess over cells, and the mixtures were incubated for 45 min at 37°C in the presence of the mAbs. The cells were washed with PBS, fixed with 2% paraformaldehyde (PFA) for 20 min on ice, and observed with a SP2 laser-scanning confocal microscope using a 100× objective. The phagocytosis index was defined as (number of phagocytosing cells) × (number of phagocytosed zymosan by each cell)/(number of total cells) 2 .
Statistical analysis
Data were expressed as mean ± SD and compared by one-way analysis of variance (ANOVA) and a post hoc test using GraphPad Prism software (San Diego, CA). Differences were considered statistically significant at P < 0.05.
